维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Trudeau ME"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Docetaxol (Taxotere) : an overview of first-line monotherapy 显示文摘	Trudeau ME	1995	Semin Oncol1995，22，613：	1
	2	Temozolomide in metastatic breast cancer(MBC):a phaseⅡtrial of the National Cancer Institute of Canada-Clinical Trials Group(NCIC-CTG)显示文摘	Trudeau ME Crump M Charpentier D	2006	Ann Oncol2006，17，6：	1
	3	Temozolomide in metastatic breast cancer (MBC):a phase Ⅱ trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG)显示文摘	Trudeau ME Crump M Charpentier D	2006	Annals of Oncology2006，17，：	1
	4	Docetaxol (Taxotere) : An overview of first-linemonotherapy 显示文摘	Trudeau ME	1995	Semin Oncol1995，22，613：	1
	5	Docetaxe:l a review of its pharmacology and clinicalactivity显示文摘	Trudeau ME	2006	Can cer2006，6，1：	1
	6	Phase Ⅰ~Ⅱ studies of docetaxel as a single agent in treatment of metastatio breast cancer 显示文摘	Trudeau ME	1999	Semin Oncol1999，26，3：	1
	7	Docetaxel in patients with metastatic breast cancer: a phase Ⅱ study of the National Cancer Institute of Canada Clinical Trials Group 显示文摘	Trudeau ME Eisenhauer EA Higgins BP	1996	J Clin Oncol11996，14，2：	1
	8	Docetaxel:a review of its pharmacology and clinical activity显示文摘		1996	Can J Oncol1996，6，1：	1
	9	Phase I-II Studies of docetaxel as a single agent in the treatment of metastatic breast cancer显示文摘	Trudeau ME	1999	Semin Oncol1999，26，3：	1
	10	Temozolomide in meta- static breast cancer (MBC) :a phase II trial of the National Cancer Institute of Canada-Clinical Trials Group (NCIC-CTG) 显示文摘	Trudeau ME Crump M Charpentier D	2006	Annals of Oncology2006，17，：	1
	11	Phase Ⅰ - Ⅱ studies of docetaxel as a single agent in the treatment of metastatic breast cancer 显示文摘	Trudeau ME	1999	Semin Oncol1999，26，8：	1
	12	Docetaxe 1 a review of its pharmacology and clinical activity显示文摘	Trudeau ME	2006	Cancer2006，6，1：	1
	13	Phase II multicenter trial of anthracycline rechallenge with pegy- lated liposomal doxoruhicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines 显示文摘	Trudeau ME Clemons MJ Provencher L	2009	J Clin Oncol2009，27，35：	1
	14	Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines显示文摘	Trudeau ME Clemons MJ Provencher L	2009	J Clin Oncol2009，27，35：	1
	15	Phase Ⅰ-Ⅱ studies of docetaxel as a single agent in the treatment of metastatic breast cancer显示文摘	Trudeau ME	1999	Semin Oncol1999，26，38：	1
	16	Docetaxel in patients with metastatic breast cancer:a phase Ⅱ study of the National Cancer Institute of Canada-Clinical Trials Group 显示文摘	Eisenhauer EA Higgins BP	1996	J Clin Oncol1996，14，：	1
	17	Docetaxel:A review of its pharmacology and clinical activity显示文摘	Trudeau ME	1996	Can J Oncol1996，6，1：	1
	18	Prognostic factors affecting the natural history of node-negative breast cancer 显示文摘	Trudeau ME Pritchard KI Chapman JA	2005	Breast Cancer Res Treat2005，89，1：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费